Stock Analysis on Net

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN)

$24.99

Common-Size Balance Sheet: Assets
Quarterly Data

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Regeneron Pharmaceuticals Inc., common-size consolidated balance sheet: assets (quarterly data)

Microsoft Excel
Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash and cash equivalents
Marketable securities
Accounts receivable, net
Inventories
Prepaid expenses and other current assets
Current assets
Marketable securities
Property, plant, and equipment, net
Intangible assets, net
Deferred tax assets
Other noncurrent assets
Noncurrent assets
Total assets

Based on: 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31).


The composition of assets at the company exhibits several notable shifts over the analyzed period, spanning from March 31, 2021, to December 31, 2025. Current assets initially represent a significant portion of the total, fluctuating between approximately 55% and 63% before declining to around 44% by the end of the period. Conversely, noncurrent assets demonstrate an increasing trend, rising from roughly 38% to 56% of total assets.

Cash and Cash Equivalents
Cash and cash equivalents as a percentage of total assets show considerable volatility. An initial increase is observed from 8.09% in March 2021 to a peak of 14.50% in September 2021, followed by a decline to 6.32% in June 2023. A subsequent rise to 8.23% in March 2025 is noted, but it remains lower than the earlier peak, concluding at 7.69% in December 2025.
Marketable Securities
Marketable securities demonstrate a generally increasing trend as a proportion of total assets, particularly from 2022 onwards. Starting at around 11-19% in 2021, the percentage rises to a high of 24.53% in September 2023, before decreasing to 25.30% by the end of the period. This suggests a growing reliance on liquid investments.
Accounts Receivable, Net
Accounts receivable, net, as a percentage of total assets, initially exhibits a high proportion, peaking at 32.57% in June 2021. A consistent downward trend is then observed, decreasing to approximately 14.16% by September 2025. This indicates improved efficiency in collecting receivables or a change in revenue recognition practices.
Inventories
The proportion of inventories to total assets remains relatively stable throughout the period, fluctuating between approximately 7.67% and 12.18%. A slight upward trend is visible towards the end of the period, reaching 8.50% in March 2025, before decreasing to 7.89% in December 2025.
Noncurrent Assets – Deferred Tax Assets & Other
Deferred tax assets and other noncurrent assets collectively show a significant increasing trend. Deferred tax assets rise from 4.31% in March 2021 to 10.05% in December 2025. Other noncurrent assets also increase, from 0.82% to 4.49% over the same period. This suggests increasing investments in long-term assets or changes in tax strategies.
Property, Plant, and Equipment, Net
Property, plant, and equipment, net, as a percentage of total assets, experiences a gradual decline from 18.36% in March 2021 to 12.62% in December 2025. This could indicate depreciation outpacing new investments in fixed assets.

In summary, the asset composition shifts from a greater reliance on current assets to a larger proportion of noncurrent assets over the analyzed timeframe. Within current assets, there is a notable decrease in accounts receivable and fluctuations in cash and marketable securities. The growth in deferred tax assets and other noncurrent assets is a significant feature of the observed changes.